Screener
Immunovant, Inc. IMVT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026. Open the filing →
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
FAQ
- What is Immunovant, Inc.'s enterprise value?
- Immunovant, Inc. (IMVT) reported enterprise value of $4.15B in Q1 2026.
- How has Immunovant, Inc.'s enterprise value changed year-over-year?
- Immunovant, Inc.'s enterprise value increased by 89.7% year-over-year, from $2.19B to $4.15B.
- What is the long-term trend for Immunovant, Inc.'s enterprise value?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s enterprise value has grown at a 28.7% compound annual growth rate (CAGR), from $1.17B to $4.15B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Immunovant, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude